Paul-Ehrlich-Institut

Go to:

Contact

Contact

Due to the coronavirus pandemic, the volume of requests has multiplied, so that we can only answer requests to a limited extent. In order to still serve as many request as possible, we are continuously expanding our range of information on the website. Please therefore check whether we have already prepared an answer on our website for your individual request:

Thank you for your understanding!

Important note: Applications for clinical trials of vaccines in Germany are examined by the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, and authorised if the data are positive. The Paul-Ehrlich-Institut is not involved in the recruitment of the study participants. This is the responsibility of the respective applicant who has the relevant information (e.g. place of implementation).

Your data

* Mandatory field

PEI Headquarter

PEI Head­quar­ter

Paul-Ehrlich-Institut
Federal Institute for Vaccines and Biomedicines
Paul-Ehrlich-Str. 51-59
63225 Langen
GERMANY

Phone: +49 6103 77 0
Email: pei@pei.de

Updated: 21.11.2019

Contact Persons

Con­tact Per­sons

Public

TopicEmail
Coronavirus Hotline for Public and Healthcare Professionals
Monday, Thursday and Friday: 10 a.m. to 1. p.m.
Tuesday and Wednesday: 2.p.m. to 5 p.m.
Phone: +49 6103 77 2222		anfragen@pei.de
Hotline for Questions from the Public and Healthcare Professionals
Tuesday: 2 p.m. to 5 p.m.
Thursday: 10 a.m. to 1 p.m.
Phone: +49 6103 77 1771		anfragen@pei.de
Requests for the Freedom of Information Act
[email protected]
Press Office
Phone: +49 6103 77 1030		presse@pei.de
Job Opportunities / Careerbewerbungen@pei.de
Contact Point Clinical Trials
For people involved in a clinical trial, their legal representative or one of their authorised representatives, pursuant to section 40 sub-section 5 AMG
Phone: +49 6103 77 1810
Fax: +49 6103 77 1277		klinpruefung@pei.de
German Haemophilia Registry
Phone: +49 6103 77 1860		dhr@pei.de
Biology Associationbiologischer-verein@pei.de
Representative of severely disabled persons
Christoph Stärk
Phone: +49 6103 77 1841		schwerbehindertenvertretung@pei.de

Regulatory Questions

TopicEmail
Innovation Office / Advice for Pharmaceutical Companiesinnovation@pei.de
Reference Material
Order of reference material for in vitro diagnostic medical devices (IVD)
Order of reference material for immunoglobulin preparations
Order of reference WHO Biological Reference Material

pei-ivd@pei.de
standard-igg@pei.de
whoccivd@pei.de
Central Office Preimplantation Genetic Diagnosis
Phone: +49 6103 4411		zpid@pei.de

Medicine Safety

TopicEmail
Pharmacovigilance
Fax: +49 6103 77 1263		pharmakovigilanz1@pei.de
Haemovigilance / Tissue Vigilance
Phone: +49 6103 77 3116 / 3117
Fax: +49 6103 77 1268		pharmakovigilanz2@pei.de
IVD-Vigilance
Phone: +49 6103 77 3114
Fax: +49 6103 77 1268		pharmakovigilanz2@pei.de
ATMP-Vigilance
Phone: +49 6103 77 3116 / 3117
Fax: +49 6103 77 1268		pharmakovigilanz2@pei.de
Pharmacovigilance (Veterinary)
Phone: +49 6103 77 1800
Fax: +49 6103 77 1279		vetmittelsicherheit@pei.de

Research

TopicEmail
Research Officer
science management, research infrastructure, research and development performance, promotion of young research fellows
PD--Private Lecturer Dr. Stephan Steckelbroeck
forschungsbeauftragter@pei.de

Adress

Paul-Ehrlich-Institut
Paul-Ehrlich-Strasse 51-59
63225 Langen
GERMANY

Updated: 04.01.2021

Requests for medical (vaccination) advice

Re­quests for med­i­cal (vac­ci­na­tion) ad­vice

The Paul Ehrlich Institut is not a clinical institution and therefore cannot offer individual vaccination advice, except information regarding the evaluation of reported suspected cases of side effects.

Also, recommendations for diagnosis and therapy are not possible, because many factors are important for appropriate medical advice, which can only be adequately considered in the personal contact between doctor and patient.

Vaccination recommendations by the Standing Committee on Vaccination (STIKO) can be found on the website of the Robert Koch-Institute (RKI).

Updated: 21.11.2019